We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Exposure to Mosquito-Transmitted Dengue May Provide Immunity Against COVID-19

By HospiMedica International staff writers
Posted on 25 Sep 2020
A study has found a link between the spread of the SARS-CoV-2 virus and previous outbreaks of dengue fever in Brazil, suggesting that exposure to the mosquito-transmitted illness could provide some immunity against COVID-19.

The study found a significant correlation between lower incidence, mortality and growth rate of COVID-19 among the Brazilian population that had higher levels of antibodies to dengue. More...
In the study that has not yet been published by the Duke University (Durham, NC, USA) but shared exclusively with Reuters, researchers compared the geographic distribution of coronavirus cases with the spread of dengue in 2019 and 2020. They found that locations that had witnessed intense dengue outbreaks in 2020 or 2019 reported lower coronavirus infection rates and a slower increase in the number of COVID-19 cases. “This striking finding raises the intriguing possibility of an immunological cross-reactivity between dengue’s Flavivirus serotypes and SARS-CoV-2,” according to the study, referring to dengue virus antibodies and the novel coronavirus. “If proven correct, this hypothesis could mean that dengue infection or immunization with an efficacious and safe dengue vaccine could produce some level of immunological protection” against SARS-CoV-2, it added.

Miguel Nicolelis, a professor at Duke University who led the study, told Reuters that the results were especially interesting given that previous studies had shown that it was possible for people with dengue antibodies in their blood to test falsely positive for COVID-19 antibodies despite never being infected by the coronavirus. The researchers found a similar relationship between dengue outbreaks and a slower spread of COVID-19 in other parts of Latin America, as well as Asia and islands in the Pacific and Indian Oceans, according to Reuters.

“This indicates that there is an immunological interaction between two viruses that nobody could have expected, because the two viruses are from completely different families,” Nicolelis told Reuters, adding that further studies are needed to prove the connection.

Related Links:
Duke University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.